Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


VitaDAO is a decentralized collective funding early stage longevity research.

VitaDAO is a new cooperative vehicle for community-governed and decentralized drug development and intellectual

property. Our core mission is the acceleration of R&D in the extension of human life and health-span. Today, the

biopharma industry booms with unprecedented late-stage investment, particularly in longevity science. However, the

industry severely lacks critical early-stage funding. Moreover, incentives between patients, researchers and industry

are misaligned, risking monopolization of lifespan extension.

At its core, biopharma value creation consists of intellectual property (IP) rights, domain-specific know-how,

and research data. Today, R&D has become prohibitively expensive and siloed, largely due to the way IP business

models incentivize the monopolization of innovation. This is done through the creation of patent thickets in protected

portfolios. These IP mechanisms prevent open sharing of research data, inherently disincentivizing collaboration and

transparency. They prevent the public and patients from having any real ownership in biopharma IP, despite their tax

dollars funding most early-stage development. Outside of grants to fund basic research, early-stage funding for drug

development is extremely limited. When drugs do finally make it to market, there exist strong incentives for price


To align incentives and vitalize early-stage funding in longevity biopharma, VitaDAO uses a combination of novel

governance frameworks in decentralized autonomous organizations (DAOs), non-fungible tokens (NFTs), and financial

engineering tools such as algorithmic automated market makers (AMMs), all of which run on the Ethereum blockchain.

As an open global cooperative that anyone can join, VitaDAO’s goal is to support and finance new therapeutics and

research data in longevity science. In exchange, VitaDAO will directly hold IP and data rights in the novel early-stage

therapeutics it supports and funds. We will grow a portfolio of IP and data assets, which we can make available and

monetize either through novel data marketplaces or by conventional licensing and commercialisation processes in

biopharma. By utilising community-guided decision-making processes, VitaDAO aims to:

1. rapidly decrease funding decision lifecycles

2. attract the worlds leading researchers by promoting open science principles

3. democratize ownership thereof

The lifeblood of VitaDAO is its native curation and governance token: VITA. Individuals or organizations can

obtain VITA tokens by contributing work, funds, or other resources like data and IP. Ownership of VITA allows the

holder to participate in the curation and governance of VitaDAOs assets and its research.

If you would like to know where to buy VitaDAO at the current rate, the top cryptocurrency exchanges for trading in VitaDAO stock are currently Uniswap (V3), and Bancor Network. You can find others listed on our crypto exchanges page.



Further Resources


A New Financial Model for Repurposing Off-Patent Longevity Medicines



December 16, 2021

FRENS: A Generalizable Legal Framework for Fractionalized IP-NFTs



February 4, 2022



Golden logo
By using this site, you agree to our Terms & Conditions.